Tag: Kjell Oberg
Oncolytic Virus Clinical Trial for Neuroendocrine Tumor Patients Begins at Uppsala University, Sweden
It is with great excitement that we share the announcement of the start of the AdVince clinical trial for neuroendocrine cancer patients at Uppsala University in Sweden – the oncolytic virus is on its way to the first patient in the trial!!
10 Highlights of the Year 2013 for the Carcinoid and Neuroendocrine Tumor Community
As the Carcinoid Cancer Foundation looks back on the year 2013, we reached out to physicians, patients, support group leaders, listserv managers, patient advocates, and business colleagues to see what they thought were among the highlights of the past…READ MORE
A Possible Cure for Neuroendocrine Cancer: Exciting Update!
Back in September 2012 we shared the following: “For $1.6 million (1 million pounds) an oncolytic virus that has the potential to cure neuroendocrine cancer can be named for the donor. At Uppsala University in Sweden researchers are ready to start a …READ MORE
Neuroendocrine Tumor Webinar Just Opened to Patients and the Public
Just opened to the patient community and the public, with limited space available, is a free live webinar featuring carcinoid and NET cancer specialist Dr. Eric Liu, Director of the Neuroendocrine Center at Vanderbilt University Medical Center in Nashville,…READ MORE